中国综合临床
中國綜閤臨床
중국종합림상
CLINICAL MEDICINE OF CHINA
2012年
10期
1056-1058
,共3页
白传明%张彬%张楠%宋书田%张志刚%边玉清%周岊梧
白傳明%張彬%張楠%宋書田%張誌剛%邊玉清%週岊梧
백전명%장빈%장남%송서전%장지강%변옥청%주절오
骨唾液蛋白%基质金属蛋白酶-9%风湿性心脏病
骨唾液蛋白%基質金屬蛋白酶-9%風濕性心髒病
골타액단백%기질금속단백매-9%풍습성심장병
Bone sialoprotein%Matrix metalloproteinase-9%Rheumatic heart disease
目的 观察骨唾液蛋白和基质金属蛋白酶-9在风湿性心脏病瓣膜的表达.方法 将手术切除的二尖瓣瓣膜按病史分为风湿性心脏病(风心病)组(120例)和非风心病组( 30例),采用SP法进行免疫组化染色观察骨唾液蛋白和基质金属蛋白酶-9的表达.结果 风心病组的骨唾液蛋白(91.6%)和基质金属蛋白酶-9 (90.8%)阳性率明显高于非风心病组骨唾液蛋白(23.3%)和基质金属蛋白酶-9(20.0%)(x2值分别为56.6354、59.4272,P均<0.01).结论 风心病瓣膜的钙化与基质金属蛋白酶-9所引起的细胞外基质降解和重塑以及骨唾液蛋白所诱导的成骨样骨形成密切相关.
目的 觀察骨唾液蛋白和基質金屬蛋白酶-9在風濕性心髒病瓣膜的錶達.方法 將手術切除的二尖瓣瓣膜按病史分為風濕性心髒病(風心病)組(120例)和非風心病組( 30例),採用SP法進行免疫組化染色觀察骨唾液蛋白和基質金屬蛋白酶-9的錶達.結果 風心病組的骨唾液蛋白(91.6%)和基質金屬蛋白酶-9 (90.8%)暘性率明顯高于非風心病組骨唾液蛋白(23.3%)和基質金屬蛋白酶-9(20.0%)(x2值分彆為56.6354、59.4272,P均<0.01).結論 風心病瓣膜的鈣化與基質金屬蛋白酶-9所引起的細胞外基質降解和重塑以及骨唾液蛋白所誘導的成骨樣骨形成密切相關.
목적 관찰골타액단백화기질금속단백매-9재풍습성심장병판막적표체.방법 장수술절제적이첨판판막안병사분위풍습성심장병(풍심병)조(120례)화비풍심병조( 30례),채용SP법진행면역조화염색관찰골타액단백화기질금속단백매-9적표체.결과 풍심병조적골타액단백(91.6%)화기질금속단백매-9 (90.8%)양성솔명현고우비풍심병조골타액단백(23.3%)화기질금속단백매-9(20.0%)(x2치분별위56.6354、59.4272,P균<0.01).결론 풍심병판막적개화여기질금속단백매-9소인기적세포외기질강해화중소이급골타액단백소유도적성골양골형성밀절상관.
Objective To investigate the expression and significance of bone sialoprotein and matrix metalloproteinase-9 in calcified mitral valves in patients with rheumatic heart disease.Methods A total of 150 mitral valves were divided into the rheumatic group (n =120) and the non-rheumatic group (n =30 ).Expressions of bone sialoprotein and matrix metalloproteinase-9 were determined by immunohistochemistry.Results Expressions of bone sialoprotein ( 91.6%,x2 =56.6354 ) and matrix metalloproteinase-9 ( 90.8%,x2 =59.4272) in the rheumatic group increased significantly than in the non-rheumatic group (P < 0.01).Conclusion Both bone sialoprotein and matrix metalloproteinase-9 are highly expressed in the calcified rheumatic group.This suggests that caficify of rheumatic mitral valves is related with the degradation and remodeling of extra cellular matricx by matrix metalloproteinase-9,as well as osteoblastlike bone formation by bone sialoprotein.